Trial intelligence / Profile preview

Oral Doxycycline vs IV Ceftriaxone for Lyme Neuroborreliosis

NCT00138801Phase 3Completed

Sponsor
Sørlandet sykehus
Start
Mar 2004
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of doxycycline (2 arms), sponsored by Sørlandet sykehus. Primary endpoint: Composite Clinical Score at 4 months. Started Mar 2004; status: completed.

02

Drugs

doxycycline

Beyond the preview

Go deeper on NCT00138801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00138801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call